Pivikto 150mg (Alpelisib Tablet) 150mg

Pivikto 150mg (alpelisib) is an oral tablet used in combination therapy for certain types of advanced breast cancer. This prescription medication targets specific pathways in cancer cells to help slow disease progression. Always use under medical supervision.

Strength

150mg

Manufacturer / TM Owner

Novartis Pharma Stein AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Pivikto 150mg is primarily used to treat advanced breast cancer in postmenopausal women or men with hormone receptor-positive, HER2-negative tumors. It is prescribed alongside other therapies, such as fulvestrant, to address cancer that has spread or cannot be surgically removed. Patients often ask, 'What is alpelisib used for?' when considering treatment options for their condition.

Side Effects

As with any medication, Pivikto 150mg may cause side effects, including fatigue, nausea, or digestive discomfort. Some users report changes in blood sugar levels or skin reactions. These effects vary by individual and should be monitored by a healthcare provider.

Precautions & Warnings

Store Pivikto 150mg at room temperature, away from moisture and direct light. Keep the medication in its original packaging until ready to use. Always handle with care and avoid crushing or splitting tablets unless instructed by a pharmacist or doctor.

Avoid Interactions

Pivikto 150mg may interact with other medications, including strong CYP3A4 inhibitors or inducers, which can alter its effectiveness. Grapefruit products and certain herbal supplements may also pose risks. Discuss all current medications with your healthcare provider before starting treatment.

Frequently Asked Questions

Pivikto 150mg is used to treat advanced breast cancer in combination with other therapies for specific tumor types.

Store at room temperature, away from moisture and light, in the original packaging.

Consult your healthcare provider before combining with other drugs to avoid potential interactions.

Common effects may include fatigue, nausea, or changes in blood sugar levels.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.